| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |